To explore the effects of mIL‐6R‐mediated signaling and mIL‐6R blockade on SIRS, we employed CRISPR‐Cas9 technology to knock in the human il‐6r gene because it is responsible for mIL‐6R expression (Figure S1A). This evidence concerns the gene IL6R and systemic inflammatory response syndrome.